Sanofi position in MPLT
MAPLIGHT THERAPEUTICS INC · Health Care
Sanofi reported holding 912,041 shares of MPLT (MAPLIGHT THERAPEUTICS INC) in its Q3 2026 13F filing — a position valued at US$9.3M, representing 1.48% of its reported portfolio and ranking #13 among its reported holdings. Sanofi has disclosed MPLT holdings in 4 of the last 4 reported quarters, going back to Q4 2025.
Last updated: 2026-11-05 · Source: SEC EDGAR Form 13F-HR
How Sanofi's MPLT position evolved
Sanofi first disclosed a stake in MPLT in Q4 2025 at 912,041 shares (US$16.0M). The position peaked in Q2 2026 at 912,041 shares, worth US$32.7M. Across 4 filings, Sanofi held the position steady without any share-count change. The most recent filing (Q3 2026) shows 912,041 shares valued at US$9.3M.
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q4 2025 | 912.04K | $16.02M | New |
| Q1 2026 | 912.04K | $18.54M | Hold |
| Q2 2026 | 912.04K | $32.69M | Hold |
| Q3 2026 | 912.04K | $9.29M | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About MPLT and 13F data
MPLT (MAPLIGHT THERAPEUTICS INC) is a Health Care company. 120 other funds we track also report a position in MPLT — the largest reported positions include Novo Holdings A/S (US$132.1M), FCPM III SERVICES B.V. (US$115.6M), Nan Fung Group Holdings Ltd (US$34.8M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding MPLT
- Novo Holdings A/S 3.69M sh · $132.13M · Q2 2026
- FCPM III SERVICES B.V. 3.23M sh · $115.63M · Q2 2026
- Nan Fung Group Holdings Ltd 971.25K sh · $34.81M · Q2 2026
- 5AM Venture Management, LLC 950.01K sh · $34.05M · Q2 2026
- Blue Owl Capital Holdings LP 729.93K sh · $26.16M · Q2 2026
- Paradigm Biocapital Advisors LP 685.85K sh · $24.58M · Q2 2026
- Pivotal bioVenture Partners Investment Advisor LLC 611.45K sh · $21.91M · Q2 2026
- Velan Capital Investment Management LP 492.89K sh · $17.67M · Q2 2026
- DAFNA Capital Management LLC 171.01K sh · $6.13M · Q2 2026
- SUPERSTRING CAPITAL MANAGEMENT LP 125.43K sh · $4.50M · Q2 2026
- STEMPOINT CAPITAL LP 106.91K sh · $3.83M · Q2 2026
FAQ
How long has Sanofi held MPLT?
Sanofi has disclosed MPLT holdings in 4 of the last 4 reported quarters, going back to Q4 2025.
What is Sanofi's current position in MPLT?
As of Q3 2026, Sanofi holds 912.04K shares of MPLT (MAPLIGHT THERAPEUTICS INC), valued at $9.29M, representing 1.48% of its reported portfolio and ranking #13.
Has Sanofi been buying or selling MPLT?
In the latest 13F filing (Q3 2026), Sanofi held unchanged its position in MPLT. The position peaked in Q2 2026 at 912.04K shares.
Which other funds hold MPLT?
Other major institutional holders of MPLT include Novo Holdings A/S, FCPM III SERVICES B.V., Nan Fung Group Holdings Ltd, among 120 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.